1.
Am J Hematol
; 99(9): 1830-1833, 2024 Sep.
Article
in English
| MEDLINE
| ID: mdl-38817040
2.
Bull Cancer
; 111(6): 544-545, 2024 Jun.
Article
in French
| MEDLINE
| ID: mdl-38631985
Subject(s)
Lymphoma, Large B-Cell, Diffuse , Humans , Lymphoma, Large B-Cell, Diffuse/drug therapy , Neoplasm Recurrence, Local/drug therapy , Male , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Antineoplastic Agents, Immunological/therapeutic use , Antineoplastic Agents, Immunological/adverse effects , Middle Aged , Aged
3.
Blood
; 143(26): 2804-2807, 2024 Jun 27.
Article
in English
| MEDLINE
| ID: mdl-38669635
ABSTRACT
ABSTRACT: Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.